Product Name: Asudemotide
CAS No: 1018833-53-8
Purity: 95%
Molar Mass: 1189.31
Chemical Formula: C58H80N10O17
Synonyms: H-DL-Glu-DL-Tyr-DL-Tyr-DL-Glu-DL-Leu-DL-Phe-DL-Val-DL-Asn-DL-xiIle-OH
Storage: Store at -20℃
Sequence: EYYELFVNX
Target: immunostimulant
Application: Asudemotide (CAS: 1018833-53-8) is a synthetic peptide-based immunomodulator with potential applications in the treatment of autoimmune diseases and cancer. It functions by selectively targeting toll-like receptor 7 (TLR7), a pattern recognition receptor involved in the innate immune response. Activation of TLR7 by asudemotide leads to the production of pro-inflammatory cytokines and chemokines, as well as the activation of antigen-presenting cells and cytotoxic T cells. This immune activation helps to enhance anti-tumor immune responses and modulate the immune system in autoimmune diseases, promoting tolerance or immune-mediated tumor cell death. In pharmaceutical chemistry, asudemotide’s targeted modulation of TLR7 represents a novel approach to immunotherapy, offering potential benefits in the treatment of various cancers and autoimmune conditions. Clinical trials are underway to evaluate its safety, efficacy, and therapeutic potential in different disease settings, with the goal of providing new treatment options for patients with unmet medical needs.
